Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies

Communications Biology(2021)10.1038/s42003-020-01552-6Source: DataRank Database

Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies is a research paper published in Communications Biology (2021). On theSindex it has a DataRank of 0. It has been cited 89 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access89 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldTopics (30)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Panji Nkhoma ORCID,Nicola Mulder ORCID,Darren P. Martin ORCID,Musalula Sinkala ORCID

Live enrichment

PubMed:33398072 PMC:PMC7782843

NHGRI NIH HHS

Grant: U24 HG006941

National Institutes of Health

Grant: 5U24HG006941-07

H3ABioNet: informatics solutions for H3Africa

goldLicense: cc-by

publisherhttps://www.nature.com/articles/s42003-020-01552-6.pdf

publisherhttps://www.nature.com/articles/s42003-020-01552-6

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7782843

repositoryhttps://doaj.org/article/65ed10c9796044daa32dcf559a6c3a18

Europe_PMChttps://europepmc.org/articles/PMC7782843

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansNeoplasmsBenzamidesDiphenylamineBenzimidazolesDrug Evaluation, PreclinicalCell SurvivalMAP Kinase Signaling SystemTranscription, GeneticMutationMCF-7 CellsA549 Cells

Keywords

Transcription, GeneticQH301-705.5Cell SurvivalMAP Kinase Signaling SystemDiphenylamineDrug Evaluation, PreclinicalArticleA549 CellsNeoplasmsBenzamidesMutationMCF-7 CellsHumansBenzimidazolesBiology (General)

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health

Additional file 1 of HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway

10.6084/m9.figshare.23535997.v1figshare

Additional file 1 of HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway

10.6084/m9.figshare.23535997figshare

Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies

FAIR Checklist

Authors (4)

Funding (2 grants)

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)